Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Multiple Myeloma Research Consortium (MMRC) and Merck Initiate Phase II Trial of Zolinza with Velcade in Relapsed and Refractory Multiple Myeloma Patients
Multiple Myeloma Research Consortium (MMRC) and Merck Initiate Phase II Trial of Zolinza with Velcade in Relapsed and Refractory Multiple Myeloma Patients
Multiple Myeloma Research Consortium (MMRC) and Merck Initiate Phase II Trial of Zolinza with Velcade in Relapsed and Refractory Multiple Myeloma Patients
Submitted by
admin
on January 17, 2009 - 9:01am
Source:
Earth Times
News Tags:
Merck
Zolinza
Velcade
Multiple Myeloma
Headline:
Multiple Myeloma Research Consortium (MMRC) and Merck Initiate Phase II Trial of Zolinza with Velcade in Relapsed and Refractory Multiple Myeloma Patients
Do Not Allow Advertisers to Use My Personal information
